Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
143 studies found for:    osteonecrosis
Show Display Options
Rank Status Study
21 Unknown  Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis
Condition: Non-Traumatic Osteonecrosis
Intervention: Drug: Alendronate
22 Unknown  Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee
Condition: Spontaneous Osteonecrosis of the Knee
Intervention: Biological: Weight reduction
23 Recruiting Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction
Condition: Bisphosphonate-Associated Osteonecrosis of the Jaw
Interventions: Drug: tooth extraction with antibiotics (amoxicillin- clavulanate, clindamycine);   Procedure: atraumatic extraction
24 Recruiting Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head
Condition: Avascular Necrosis of Femur Head
Interventions: Biological: XCEL-MT-OSTEO-ALPHA;   Procedure: Standard treatment
25 Recruiting Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head
Condition: Osteonecrosis
Intervention: Procedure: core decompression
26 Completed Transcription Factor Runx2 in Necrotic Femoral Head Tissue
Condition: Osteonecrosis of Femoral Head
Interventions: Procedure: osteonecrosis of femoral head group;   Procedure: osteoarthritis group
27 Completed Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled Trial
Conditions: Osteonecrosis of the Knee;   Bone Marrow Edema of the Knee
Interventions: Drug: Ibandronate IV;   Drug: Placebo
28 Completed Treatment of Osteonecrosis of the Femoral Head by Bone Marrow Transplantation
Condition: Necrosis
Interventions: Procedure: core decompression;   Procedure: Bone marrow implantation into the necrotic lesion
29 Active, not recruiting Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis
Condition: Osteonecrosis
Interventions: Procedure: Control group;   Biological: Mononuclear Cells;   Biological: Platelets;   Drug: Zoledronic Acid;   Drug: Normal saline
30 Completed Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
Conditions: Bone Diseases;   Metastases;   Osteonecrosis;   Bisphosphonate-Associated Osteonecrosis of the Jaw
Intervention:
31 Unknown  Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head
Condition: Osteochondritis of the Femoral Head
Interventions: Biological: mesenchymal stem cell infusion;   Biological: bone marrow mononuclear cell infusion
32 Recruiting Osteonecroses in Pediatric Patients With ALL
Conditions: Osteonecrosis;   Acute Lymphoblastic Leukaemia;   Lymphoblastic Lymphoma
Intervention:
33 Recruiting Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
Condition: Osteonecrosis
Intervention:
34 Active, not recruiting Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid
Conditions: ONJ;   Infection
Intervention:
35 Enrolling by invitation Autologous Bone Marrow Stem Cell Transplantation for Hip Osteonecrosis in Sickle Cell Disease
Conditions: Avascular Necrosis of Femur Head;   Sickle Cell Disease
Interventions: Procedure: Stem Cell Graft Group;   Biological: Autologous bone marrow stem cell
36 Active, not recruiting S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Multiple Myeloma;   Plasma Cell Neoplasm;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: assessment of therapy complications
37 Completed Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw
Conditions: Solid Tumours;   Bone Metastasis
Intervention: Other: Physician Survey
38 Completed Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head
Condition: Avascular Necrosis of Femur Head
Interventions: Drug: Core decompression/PREOB® implantation;   Drug: Core decompression/BMC implantation
39 Active, not recruiting Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively
Conditions: Osteoarthritis, Knee;   Osteonecrosis
Intervention:
40 Recruiting Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis
Conditions: Aseptic;;   Hip Necrosis
Interventions: Drug: ibandronate;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.